drugset / Trial / NCT04533464
MultiStem® for Treatment of Trauma Induced Multiple Organ Failure/Systemic Inflammatory Response Syndrome
Phase 2
Unknown
156 enrolled
Healios K.K.
Memorial Hermann Hospital · collabUnited States Department of Defense · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Single center, prospective, randomized, double-blind, pragmatic Phase 2 clinical study in severely injured trauma patients within hours of hospitalization who have survived initial resuscitation.
Timeline
- Start
- 2020-11-09
- Primary completion
- 2025-12
- Completion
- 2025-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MultiStem | Cell therapy | — | Intravenous |
Indications
No indication recorded.